High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

By Davidson Ben   Goldberg Iris   Gotlieb Walter   Kopolovic Juri   Ben-Baruch Gilad   Nesland Jahn   Berner Aasmund   Bryne Magne   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 17, Iss. 10, 1999-12 ,pp. : 799-808

Springer Publishing Company

Access to resources Recommend Favorite

MMP-2 and TIMP-2 Expression Correlates with Poor Prognosis in Cervical Carcinoma-A Clinicopathologic Study Using Immunohistochemistry and mRNA in Situ Hybridization

By Davidson B.   Goldberg I.   Kopolovic J.   Lerner-Geva L.   Gotlieb W.H.   Ben-Baruch G.   Reich R.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 372-382

Elsevier

Access to resources Recommend Favorite

Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer

By            

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 1049-1057

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of MMP2, MMP9, TIMP1, TIMP2, NGAL and MMP9/NGAL complex in urine and sera from patients with bladder cancer

By      

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2527-2532

Spandidos Publications

Access to resources Recommend Favorite

Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

By Davidson B.   Reich  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2040-2049

Elsevier

Access to resources Recommend Favorite